Gildead ends remdesivir trial after inconclusive results

Yahoo Finance’s Brian Sozzi, Alexis Christoforous, and Heidi Chung discuss the latest market action for Gilead Sciences. …read more

Source:: Yahoo Finance

Discover Tomorrow’s Winning Stocks!
Get our latest stock reports before everyone else! Actionable news, and breakout stocks w multi-bagger upside potential — delivered directly to your inbox.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.